Product Details

CEFEXICLAV POWDER FOR ORAL SUSPENSION 50MG/31.25MG/5ML*

Cefixime; Clavulanic Acid (Clavulanate Potassium)
50 mg/5 mL; 31.25 mg/5 mL
Suspension

ROA

Oral

Applicant Name

SJS Life Sciences Limited

NRN

B4-6583

Status

Active


Composition

 

ATC Code

J01DD08  

Product Category

Drugs

Marketing Category

Prescription-only Medicine (POM)  

Packsize

1X100ML  

Product Description

149 CMS-PP-233255 CEFEXICLAV POWDER FOR ORAL SUSPENSION 50MG/31.25MG/5ML CEFIXIME 50MG + CLAVULANIC ACID 31.25MG Cefixime Trihydrate Eq to Cefixime (A) 50mg, Diluted Potassium Clavulanate Eq. to Clavulanic Acid (A) 31.25mg, Sucrose (D)$ 937mg, Colloidal Anhydrous Silica 15mg, Carmellose Sodium (Sodium Carboxymethylcellulose) 25mg, Sodium Citrate 11.25mg, Sodium Benzoate 1.04mg, Essence Orange Powder (Firemenich) 13.10mg, Aspartame 6.360mg, Disodium Edetate 10mg B4-6583 Drugs Imported Products 1*100ML Prescription Only Medicine (POM) 10/5/2021 SJS LIFE SCIENCES LIMITED, 11, OLU AKERELE STREET, IKEJA, LAGOS 8114441430 sjslifesciencesltd@gmail.com GLOBELA LABORATORIES PRIVATE LIMITED, PLOT NO. 5536, ROAD NO. 55, G.I.D.C. ESTATE, SACHIN, SURAT – 394 230, INDIA, India

Manufacturer Name

Globela Pharma Pvt Ltd

Manufacturer Country

INDIA  

Approval Date

2023-07-06  

Expiry Date

2028-07-05